Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Human hepatitis B vaccine from recombinant yeast.Nature. 1984; 307: 178-180
- Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA.JAMA. 1984; 251: 2812-2815
- Recombinant yeast hepatitis B vaccine: Immunogenicity and safety.Hepatology. 1984; 4: 1077
- Clinical evaluation of a recombinant hepatitis B vaccine.Lancet. 1984; ii: 1174-1175
- Immunogenicity of recombinant yeast hepatitis B vaccine.Lancet. 1985; i: 108-109
- Safety and immunogenicity of a recombinant hepatitis B vaccine.J Med Virol. 1985; 17: 57-62
- Recombinant yeast human hepatitis B vaccine.J Hong Kong Med Assoc. 1985; 37: 75-85
- Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine.Antiviral Res. 1985; : 273-279
- Anti-HBs responses to vaccination with a human hepatitis B vaccine made by recombinant DNA technology to yeast.J Infect Dis. 1986; 153: 156-159
- Response to hepatitis B vaccine in a young adult population.in: Szmuness W Alter HJ Maynard JE Viral hepatitis. Franklin Institute Press, Orlando, Florida1982: 451-466